SEC Form 4/A · accession 0001610717-26-000333
Omada Health, Inc. · OMDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Craig Gracey
Officer — Chief Accounting Officer
Period of report
Jun 24, 2026
Accepted (ET)
Jul 8, 2026 · 8:20 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001611115
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 24, 2026 | M | 2,083 | $6.57 | A | 17,524 | D | |
| Common StockF3,F1 | Jun 24, 2026 | S | 2,083 | $19.0118 | D | 15,441 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $6.57 | Jun 24, 2026 | M | 2,083 | D | — | Oct 23, 2034 | Common Stock | 2,083 | 39,584 | D |
Explanation of responses
- F1This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- F2Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F3This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F425% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.